clinical-trials-2017-scientifictracks-abstracts

21 / 46

Page 62
Notes:
conferenceseries.com
Volume 7, Issue 5 (Suppl) J Clin Trials, an open access journal
ISSN:2167-0870 Clinical Trials 2017
September 11-13, 2017
September 11-13, 2017 San Antonio, USA
4th International Conference on
Cl inical Tr ial s
Trial promoter: Aweb-based tool for boosting the promotion of clinical research through social media
Katja Reuter
University of Southern California, USA
Participant recruitment intoclinical trials represents amajor barrier toclinical and translational researchand is oftenassociated
with implementation delays and high costs. This hinders the translation of scientific discoveries into interventions that
improve the health of individuals and the public across populations. Numerous barriers to clinical trial participant recruitment
have been identified, including the lack of awareness among patients that trials are available. Several groups have demonstrated
that social media such as Facebook and Twitter can be used to reach and enroll participants efficiently into clinical studies. To
scale up the number of clinical trials that could potentially benefit from dissemination via SM, we developed and successfully
tested trial promoter, a tool that automates the generation, distribution and assessment of clinical trial recruitment messages via
social media. In order to test the tool and the correctness of the generated messages, clinical trials (n=46) were randomized into
social media messages and distributed via the microblogging social media platform Twitter and the social network Facebook.
The percent correct was calculated to determine the probability with which trial promoter generates accurate messages. During
a 10-week testing phase, Trial Promoter automatically generated and published 525 social media messages on Twitter and
Facebook. On average, trial promoter correctly used the message templates and substituted the message parameters (text,
URLs, and disease hashtags) 97.7% of the time (1563/1600). Trial promoter may serve as a promising tool to render clinical
trial promotion more efficient while requiring limited resources.
Biography
Katja Reuter is an Assistant Professor of Clinical Preventive Medicine at the Institute for Health Promotion and Disease Prevention Research at the Department
of Preventive Medicine, Keck School of Medicine of the University of Southern California (USC), and Director of Digital Innovation and Communication at the
Southern California Clinical and Translational Science Institute at USC. She is a Scientist, Educator, and a Communications Professional trained and employed in
Germany, New Zealand and the United States of America (USA) with over 15 years’ experience. She received her PhD in Developmental Neuroscience from the
Free University in Berlin, Germany.
Katja Reuter, J Clin Trials 2017, 7:5 (Suppl)
DOI: 10.4172/2167-0870-C1-019